Agents

• Albiglutide (Tanzeum) (see Albiglutide): approved in 2014
• Dulaglutide (Trulicity) (see Dulaglutide): approved in 2014
• Exenatide (Byetta, Bydureon) (see Exenatide): approved in 2005/2012
• Liraglutide (Victoza, Saxenda) (see Liraglutide): approved in 2010
• Lixisenatide (Lyxumia in Europe, Adlyxin in the United States) (see Lixisenatide): approved in 2016
• Semaglutide (Ozempic, Rybelsus, Wegovy) (see Semaglutide): approved in 2017

---

Indications

Type 2 Diabetes Mellitus (see Diabetes Mellitus)

• xxxx

---

References

• xxx